We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Pacing System Helps Wean COVID-19 Patients Off Ventilators

By HospiMedica International staff writers
Posted on 29 Apr 2020
A novel device conditions a patient's diaphragm to reduce ventilator-induced diaphragm dysfunction (VIDD), which can prolong ventilation time.

The Synapse Biomedical (Oberlin, OH, USA) TransAeris Diaphragm Pacing System (DPS) is a temporary percutaneous intramuscular diaphragm stimulator intended for patients at risk of or on prolonged positive pressure mechanical ventilation. More...
The system is composed of the external TransAeris stimulator and one or two TransLoc electrodes, which are inserted into the right, left, or both hemi-diaphragms. The electrodes are hooked up the stimulator via surface pad electrodes and a pair of color-coded frictionless connectors. Clinical control is via a built-in user interface.

The TransAeris then provides neuromuscular electrical stimulation to the diaphragm while the patient is on mechanical ventilation to prevent, slow, or reverse diaphragm disuse atrophy and, more generally, to treat VIDD. Once the patient is successfully extubated after mechanical ventilation, the electrodes are removed from the diaphragm. The entire system is disposed of after use, thus avoiding any transfer of nosocomial infections in the intensive care unit (ICU) environment. The system has received U.S. Food and Drug Administration (FDA) emergency use authorization during the COVID-19 Pandemic.

“Trauma and high-risk surgical and cardiac patients will continue to require ICU beds and ventilators that are also needed for COVID-19 patients,” said Professor Raymond Onders, MD, chief of general surgery at University Hospitals Cleveland Medical Center (OH, USA). “In our case, utilizing TransAeris for high risk surgical and COVID-19 patients is protecting the supply chain of ventilators, ICU beds, and clinical resources by reducing the time spent on mechanical ventilators by patients at risk or experiencing prolonged mechanical ventilation.”

Weaning is an essential and universal element in the care of critically ill intubated patients receiving mechanical ventilation, and covers the entire process of liberating the patient from mechanical support and from the endotracheal tube. It is estimated that 40% of the duration of mechanical ventilation is dedicated to the process of weaning. In some cases the process is rapid and uneventful; however, for some patients the process may be prolonged for days or weeks, due to inspiratory muscle atrophy, fatigue, paralysis of the diaphragm, or a fear of suffocation.

Related Links:
Synapse Biomedical


Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Endoscopy Display
E190
Emergency Ventilator
Shangrila935
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.